Search research articles
Contact Us
Filters
Showing results (301-310 of 394) with videos related to
Page
of 40
Sort By:
The Journal of Rheumatology
|
April 16, 2022
Secukinumab in United States Biologic-Naïve Patients With Psoriatic Arthritis: Results From the Randomized, Placebo-Controlled CHOICE Study
Tien Nguyen, Melvin Churchill, Robert Levin, et al.
The New England Journal of Medicine
|
October 19, 2017
Tofacitinib or Adalimumab versus Placebo for Psoriatic Arthritis
Philip Mease, Stephen Hall, Oliver FitzGerald, et al.
The Journal of Investigative Dermatology
|
October 3, 2024
A Scalable Approach to Assess the Safety of Recently Marketed Systemic Treatments for Atopic Dermatitis in Clinical Practice: First Analysis Cycle of a Sequential Monitoring System
Maria C Schneeweiss, Robert J Glynn, Richard Wyss, et al.
RMD Open
|
September 28, 2022
Comparative performance of composite measures from two phase III clinical trials of ixekizumab in psoriatic arthritis
Laura C Coates, Josef S Smolen, Philip J Mease, et al.
Rheumatology and Therapy
|
September 8, 2022
Identifying and Quantifying the Role of Inflammation in Pain Reduction for Patients With Psoriatic Arthritis Treated With Tofacitinib: A Mediation Analysis
Kurt de Vlam, Philip J Mease, Andrew G Bushmakin, et al.
RMD Open
|
March 10, 2026
Bimekizumab longer-term safety profile in adult patients with axial spondyloarthritis or psoriatic arthritis: an updated analysis of six phase IIb/III clinical studies
Philip J Mease, Joseph F Merola, Marina Magrey, et al.
Biorxiv : the Preprint Server for Biology
|
November 24, 2025
Single Cell Analysis of pBMCs of Psoriasis patients reveals distinct CD4+ T cell phenotypes associated with response to IL-23 blockade
Kathryne E Marks, Anina Sun, Ifeoluwakiisi Adejoorin, et al.
Rheumatology and Therapy
|
August 19, 2023
Six-Month Persistence and Multi-domain Effectiveness of Guselkumab in Adults with Psoriatic Arthritis: Real-World Data from the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry
Philip J Mease, Alexis Ogdie, John Tesser, et al.
Dermatology and Therapy
|
February 15, 2022
A Practical Guide to the Management of Oral Candidiasis in Patients with Plaque Psoriasis Receiving Treatments That Target Interleukin-17
April W Armstrong, Andrew Blauvelt, Ulrich Mrowietz, et al.
The Journal of Investigative Dermatology
|
January 26, 2025
Construct Validity of the IDEOM Musculoskeletal Questionnaire: An Instrument to Measure Musculoskeletal Symptoms in Patients with Psoriatic Disease
Lourdes M Perez-Chada, George Gondo, Carly Grant, et al.
Page
of 40
Search research articles
Search
Showing results (301-310 of 394) with videos related to
Sort By:
Page
of 40
The Journal of Rheumatology
|
April 16, 2022
Secukinumab in United States Biologic-Naïve Patients With Psoriatic Arthritis: Results From the Randomized, Placebo-Controlled CHOICE Study
Tien Nguyen, Melvin Churchill, Robert Levin, et al.
The New England Journal of Medicine
|
October 19, 2017
Tofacitinib or Adalimumab versus Placebo for Psoriatic Arthritis
Philip Mease, Stephen Hall, Oliver FitzGerald, et al.
The Journal of Investigative Dermatology
|
October 3, 2024
A Scalable Approach to Assess the Safety of Recently Marketed Systemic Treatments for Atopic Dermatitis in Clinical Practice: First Analysis Cycle of a Sequential Monitoring System
Maria C Schneeweiss, Robert J Glynn, Richard Wyss, et al.
RMD Open
|
September 28, 2022
Comparative performance of composite measures from two phase III clinical trials of ixekizumab in psoriatic arthritis
Laura C Coates, Josef S Smolen, Philip J Mease, et al.
Rheumatology and Therapy
|
September 8, 2022
Identifying and Quantifying the Role of Inflammation in Pain Reduction for Patients With Psoriatic Arthritis Treated With Tofacitinib: A Mediation Analysis
Kurt de Vlam, Philip J Mease, Andrew G Bushmakin, et al.
RMD Open
|
March 10, 2026
Bimekizumab longer-term safety profile in adult patients with axial spondyloarthritis or psoriatic arthritis: an updated analysis of six phase IIb/III clinical studies
Philip J Mease, Joseph F Merola, Marina Magrey, et al.
Biorxiv : the Preprint Server for Biology
|
November 24, 2025
Single Cell Analysis of pBMCs of Psoriasis patients reveals distinct CD4+ T cell phenotypes associated with response to IL-23 blockade
Kathryne E Marks, Anina Sun, Ifeoluwakiisi Adejoorin, et al.
Rheumatology and Therapy
|
August 19, 2023
Six-Month Persistence and Multi-domain Effectiveness of Guselkumab in Adults with Psoriatic Arthritis: Real-World Data from the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry
Philip J Mease, Alexis Ogdie, John Tesser, et al.
Dermatology and Therapy
|
February 15, 2022
A Practical Guide to the Management of Oral Candidiasis in Patients with Plaque Psoriasis Receiving Treatments That Target Interleukin-17
April W Armstrong, Andrew Blauvelt, Ulrich Mrowietz, et al.
The Journal of Investigative Dermatology
|
January 26, 2025
Construct Validity of the IDEOM Musculoskeletal Questionnaire: An Instrument to Measure Musculoskeletal Symptoms in Patients with Psoriatic Disease
Lourdes M Perez-Chada, George Gondo, Carly Grant, et al.
Page
of 40